Hyperpigmentation problem and a new method for solving it

Goal. To assess the efficacy and safety of Neoton serum and cream for the treatment of chloasma. Materials and methods. Ten women aged 25—60 suffering from chloasma received Neoton (Neoton cream in the morning and Neoton serum in the evening) for a month. The level of melanin in lesion foci was determined prior to and after the treatment using the Multi Skin Test Center MC 750 (Germany). Results. Prior to the treatment, the level of melanin ranged from 89 to 124 (for normal skin: from 6 to 40). The treatment with Neoton drugs resulted in a complete regression of eruptions in 30% of the women, substantial improvement in 60% of the patients and improvement in 10% of them. A reduction in the level of melanin ranging from 15 to 68 serves as an objective proof of the drug efficacy. Neither of the patients developed any adverse effects. Conclusion. Good tolerance and efficacy of Neoton serum and cream for the treatment of hyperpigmentation (chloasma) were demonstrated.

melanin, hyperpigmentation, chloasma, Neoton Radiance cream, Neoton serum